Nov, 12, 2021, the Chinese People's Association for Friendship with Foreign Countries (CPAFFC) and China Friendship Foundation for Peace and Development (CFFPD) initiated a donation of COVID-19 nucleic acid test kits and sample releaser buffer (worth RMB 12.8 million) to Pakistan. The donation ceremony was held at the Pakistani embassy in Beijing. Vice President of the Chinese People’s Association for Friendship with Foreign Countries, Chairman of the China Friendship and Peace Development Foundation, Li Xikui, Pakistan’s Ambassador to China, Moin ul Haque, Ambassador of the China-Pakistan Friendship Association Changsha Zukang, Secretary-General of the China Friendship and Peace Development Foundation, Wang Longshe, Chinese People Luan Yutao, deputy director of the Asian-African Work Department of the Association for Friendship with Foreign Countries, and Wang Rui, a diplomat of the Pakistani Embassy in China, deputy general manager of Wuhan Wuhan EasyDiagnosis Biomedicine Co., Ltd., and about 35 Chinese and foreign media attended the ceremony.

This batch of materials were donated by Wuhan EasyDiagnosis Biomedicine Co., Ltd. The total value is RMB 12.8 million, including 100,000 test kits and 100,000 sample releaser buffers independently developed and produced by the company. The supplies will be used to support Pakistan in its fight against COVID-19 through providing 100,000 nucleic acid tests for COVID-19.

Anti-epidemic materials donated by EasyDiagnosis Biomedicine

Li Xikui actively mobilized non-governmental forces to raise Pakistan’s urgent need for anti-epidemic supplies, and expressed solidarity and support for Pakistan’s anti-epidemic work with practical actions, fully demonstrating the unbreakable “iron” friendship between China and Pakistan. He mentioned that this year marks the 70th anniversary of the establishment of diplomatic relations between China and Pakistan. The Chinese People’s Association for Friendship with Foreign Countries is willing to work with people from all walks of life in the two countries to strengthen unity and cooperation, and work together to build a closer China-Pakistan community of shared future in the new era to better benefit the two countries and peoples.

Li Xikui, Vice Chairman of the Chinese People's Association for Friendship with Foreign Countries, delivered a speech.

Pakistan’s Ambassador to China Moin ul Haque praised the Chinese People’s Association for Friendship with Foreign Countries and the China Friendship and Peace Development Foundation for their timely assistance to the Pakistani people. He mentioned that with the global outbreak of the COVID-19, the brotherhood between Pakistan and China has once again withstood the test of history and is even more precious. China’s successful experience in fighting the epidemic is worth learning from Pakistan and has set an example for the world. He said that Pakistan is willing to take the 70th anniversary of the establishment of diplomatic relations between Pakistan and China as an opportunity to further strengthen exchanges and cooperation with the Chinese People's Association for Friendship with Foreign Countries and the China Friendship and Peace Development Foundation, promote the continuous development of Pakistan-China friendly relations, and jointly promote the construction of closer relations of the Pakistan-China Community of Shared Future.

Pakistani Ambassador to China Moin ul Haque delivered a speech.

Wang Rui, deputy general manager of Wuhan EasyDiagnosis Biomedicine Co., Ltd, stated that Wuhan Wuhan EasyDiagnosis Biomedicine Co., Ltd, as a local biomedical company in Wuhan, has always actively participated in the anti-epidemic work. The self-developed new crown nucleic acid detection kit has been widely recognized, serving more than 2,000 medical institutions, and supplying more than 200 million reagents. He mentioned that Wuhan Easy has never stopped fighting against the new crown, and has continued to launch a number of services and products such as the overall solution of new crown detection products and services, the PCR laboratory construction program, and the emergency and critical disease detection program. He said that Wuhan EasyDiagnosis Biomedicine Co., Ltd will actively participate in friendly exchanges and cooperation between China and Pakistan, and do its best to provide assistance to Pakistan, show the responsibility and responsibility of Chinese private enterprises, and contribute to the global anti-epidemic action.

Wang Rui, Deputy General Manager of Wuhan EasyDiagnosis Biomedicine, delivers a speech.

At the donation ceremony, the staff of Wuhan EasyDiagnosis Biomedicine Co., Ltd demonstrated the whole process of COVID-19 nucleic acid detection sampling, sample release, and computer testing.

COVID-19 nucleic acid detection demonstration site.

Ambassador Moin ul Haque presented a certificate of appreciation to Deputy General Manager Wang Rui.

In the diagnosis and treatment of COVID-19, highly sensitive, highly specific, and rapid new coronavirus nucleic acid testing products play an irreplaceable role in epidemic prevention and control and clinical diagnosis of suspected patients. COVID-19 Nucleic Acid Test kit produced by Wuhan EasyDiagnosis Biomedicine Co., Ltd has good compatibility; the detection speed is fast compared with similar fluorescent PCR kits in the market, which can save 30-40 minutes of detection time; the sensitivity can reach the level of the National Sensitivity Reference Product S6 of the China Inspection Institute, and the precision is high ; It can effectively and quickly support the diagnosis of new coronavirus patients, meet the rapid detection needs of epidemic scenes around the world, and better assist the international new crown epidemic prevention and control work. The kit has been approved by the National Medical Products Administration (NMPA) and EU CE access, and the product quality has been recognized by Germany, Italy, South Africa, Poland, Bolivia, Bangladesh and other countries and regions.

In the future, Wuhan EasyDiagnosis Biomedicine Co., Ltd will continue to innovate medical products and services and make greater contributions to the cause of human health relying on its professional R&D and innovation strength!